Karus is a leader in the design and development of innovative cancer therapeutics. Our orally-active, small molecule drugs combine targeted cancer cell activity with immunotherapy for the treatment of hematological and solid tumors. We have taken a concept-to-clinic approach, having designed and developed our therapeutic agents from research through pre-clinical development and, subsequently, to early stage clinical trials.


Genesis Building, Library Avenue

Other organisations on campus